Trends in the Cost and Utilization of Publicly Dispensed Respiratory Inhalers in Ontario, Canada: A Repeated Cross‐Sectional Study
Public formulary listing of combination therapy inhalers, namely LAMA/LABA in Q2 of 2015, coincided with a significant decline in per-beneficiary spending on respiratory inhalers.
Authors
- Tianru Wang (ORCID: https://orcid.org/0000-0002-8221-5720)
- Mina Tadrous (ORCID: https://orcid.org/0000-0003-1911-6129)
- Tara Gomes (ORCID: https://orcid.org/0000-0002-1468-1965)
- Tony Antoniou (ORCID: https://orcid.org/0000-0002-6984-8953)
- Ria Garg (ORCID: https://orcid.org/0000-0003-2572-0170)
Institutions
- St. Michael's Hospital (CA)
- University of Toronto (CA)
Publication Details
- Journal
- Pharmacoepidemiology and Drug Safety
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1002/pds.70125
- Primary Topic
- Inhalation and Respiratory Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00